BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10962136)

  • 61. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Three countries' experience with Norplant introduction.
    Hardee K; Balogh S; Villinski MT
    Health Policy Plan; 1997 Sep; 12(3):199-213. PubMed ID: 10173401
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
    Phemister DA; Laurent S; Harrison FN
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):175-9. PubMed ID: 7847530
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants [corrected] a possible role in progestin-induced bleeding.
    Shaamash AH; Zakhari MM
    Hum Reprod; 2005 Jan; 20(1):302-6. PubMed ID: 15471931
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Norplant implants: the mechanism of contraceptive action.
    Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nonmenstrual adverse events associated with subdermal contraceptive implants containing normegestrel and levonorgestrel.
    Arowojolu AO; Ladipo OA
    Afr J Med Med Sci; 2003 Mar; 32(1):27-31. PubMed ID: 15030062
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle.
    Critchley HO; Bailey DA; Au CL; Affandi B; Rogers PA
    Hum Reprod; 1993 Oct; 8(10):1632-9. PubMed ID: 8300819
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of the chemokines, monocyte chemotactic protein (MCP)-1 and MCP-2 in endometrium of normal women and Norplant users, does not support a central role in macrophage infiltration into endometrium.
    Hampton AL; Rogers PA; Affandi B; Salamonsen LA
    J Reprod Immunol; 2001 Feb; 49(2):115-32. PubMed ID: 11164897
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endometrial endothelin: regulator of uterine bleeding and endometrial repair.
    Salamonsen LA; Marsh MM; Findlay JK
    Clin Exp Pharmacol Physiol; 1999 Feb; 26(2):154-7. PubMed ID: 10065338
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effects of vitamin E supplementation on endometrial thickness, and gene expression of vascular endothelial growth factor and inflammatory cytokines among women with implantation failure.
    Hashemi Z; Sharifi N; Khani B; Aghadavod E; Asemi Z
    J Matern Fetal Neonatal Med; 2019 Jan; 32(1):95-102. PubMed ID: 28847198
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative observation of the changes in serum lipid peroxides influenced by the supplementation of vitamin E in burn patients and healthy controls.
    Zhang MJ; Wang QF; Gao LX; Jin H; Wang ZY
    Burns; 1992 Feb; 18(1):19-21. PubMed ID: 1558667
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction.
    Belsey EM; Machin D; d'Arcangues C
    Contraception; 1986 Sep; 34(3):253-60. PubMed ID: 3539509
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design and evaluation of a subcutaneous contraceptive implant training simulator.
    Dery SKK; Kaufmann EE; Marzano D; Deininger M; Asem CK; Sienko KH
    Int J Gynaecol Obstet; 2019 Oct; 147(1):36-42. PubMed ID: 31241761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.